Overview

Effect of ATI-7505 on Gastrointestinal Transit in Healthy Volunteers

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
This is a pharmacodynamic study in healthy volunteers to determine the effects of a new 5-HT4 agonist on gastric, small bowel and colonic transit.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
ARYx Therapeutics
Treatments:
ATI 7505